Toggle light / dark theme

NEW YORK (Reuters Health) — A convolutional neural network trained through deep learning can accurately predict a person’s age and gender using only standard 12-lead ECG signals, researchers report.

“Our standard diagnostic tools may have far more information behind them than we’ve come to expect throughout standard approaches to diagnostic interpretation,” said Dr. Suraj Kapa from Mayo Clinic College of Medicine, in Rochester, Minnesota.

“Between this study and other prior studies showing that we can predict likelihood of having atrial fibrillation from a normal sinus ECG or the presence of a low ejection fraction, AI-enabled ECG analysis may offer new, rapid, and cost-effective insights into human health well beyond what we could have anticipated in the last two centuries since the ECG was first developed,” he told Reuters Health by email.

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark, interviews James Strole, Co-Founder and Co-Director of People Unlimited and Director of the Coalition For Radical Life Extension.

Ira Pastor Comments:

On the last several shows we have spent time on different hierarchical levels the biologic-architecture of the life, disease and aging process. We’ve spent some time talking about the genome, the microbiome, tissue engineering, systems biology, quantum biology, organism hydrodynamics, biosemiotics, and chronobiology.

As exciting and promising as all of these research paths are, at the end of the day, in order for them to yield what many of us are looking for, radically extended healthspans and lifespans, and for them to be translated at scale, that is: approved by regulators, marketed by large pharma and CPG companies, and prescribed by a millions of clinicians (especially as the target market is all 7+ billion inhabitants of the planet), there needs to be an appropriate system of advocacy, education, awareness, and networking built around them to spread the word of the possibilities and the beautiful future that they can bring.

For today’s guest, I could think of no one better to come talk with us about this topic and take us into the future, than James Strole.

James is the Co-Founder and Co-Director of People Unlimited, an organization that’s involved in inspiring, educating, and connecting like minded people interested in achieving unlimited lifespans.

A new study in healthy adults suggests that antibiotics may reduce the effectiveness of the flu vaccine.

The depletion of gut bacteria by antibiotics appears to leave the immune system less able to respond to new challenges, such as exposure to previously unencountered germs or vaccines, said Bali Pulendran, Ph.D., professor of pathology and of microbiology and immunology at the Stanford University School of Medicine.

“To our knowledge, this is the first demonstration of the effects of broad-spectrum antibiotics on the immune response in human—in this case, our response to vaccination—directly induced through the disturbance of our gut bacteria,” he said.

A small clinical trial, which was conducted by a team of researchers led by Dr. Greg Fahy, has shown for the first time in humans that reversing biological age may be possible.

The results of TRIIM are in

The researchers spent a year running the Thymus Regeneration, Immunorestoration, and Insulin Mitigation (TRIIM) trial, which included 9 volunteers aged between 51 and 65. The trial was aimed at testing if a growth hormone and drug combination could be used safely in humans to restore thymic function lost due to aging [1].

Alex Eskin, a mathematician at the University of Chicago, has won the $3 million 2019 Breakthrough Prize in Mathematics.

The Breakthrough Prizes were founded in 2013 by a group of tech billionaires (as well as multihundred millionaire Anne Wojcicki, co-founder and CEO of genomics and biotech company 23andMe). The prizes are awarded each year to researchers in mathematics, fundamental physics and the life sciences. Past winners decide who will win in each category.

A 5 year study. In recent years it has been shown to extend the lives of nematodes (or roundworms) by 57% and mice by 6%. In humans, claims abound that metformin-takers are living longer, having fewer cardiovascular episodes and seeing reduced odds of getting cancer.


Groundbreaking TAME trial, which directly targets aging as an endpoint, finally begins this November, reveals lead clinician Dr Nir Barzilai.

Physicists at LMU have developed a highly sensitive method for measuring the mechanical stability of protein conformations, and used it to monitor the early steps in the formation of blood clots.

As the central mediators of cell function in biological organisms, proteins are involved in the execution of virtually all cellular processes. They provide the internal scaffolding that gives cells their form, and enable cells to dynamically alter their morphology. They transport substrates back and forth across membranes, and they catalyze most of the that take place in cells. In the course of these tasks many proteins are subjected to external forces. Indeed, some “mechanosensitive” proteins effectively measure the strength of the forces acting upon them and are activated when the imposed exceeds a given threshold value. Von Willebrand Factor (VWF), which initiates the formation of blood clots, is an important representative of this class.

The mechanical forces required to activate proteins like VWF are often so small that their magnitude could not be determined using existing methods. Now, a team of scientists led by LMU physicists Dr. Martin Benoit and Professor Jan Lipfert has developed a much more sensitive procedure. Their “magnetic tweezers” can quantify forces that are 100 times smaller than the commonly used alternative method currently available. As Lipfert and colleagues report in the journal PNAS, they have employed the technique to observe the unfolding of the VWF protein under the influence of low mechanical forces.